New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Vyome Holdings, Inc. (HIND) vs Lexaria Bioscience Corp. (LEXX)
- Vyome Holdings, Inc. HIND 1.20 −17.24%
- Lexaria Bioscience Corp. LEXX 4.03 −10.24%
Vyome Holdings, Inc. and Lexaria Bioscience Corp. are both Biotechnology companies. Vyome Holdings, Inc. and Lexaria Bioscience Corp. are of similar size ($10.2M and $9.5M). Lexaria Bioscience Corp. grew revenue faster over the last twelve months: 52.0% against −55.6%. Lexaria Bioscience Corp. has the higher net margin (−1,686.1% vs −2,453.9%) and the lower return on invested capital (−662.6% vs 0.00%). Across the 18 metrics below, Lexaria Bioscience Corp. leads on 11 and Vyome Holdings, Inc. on 7.
Valuation
Profitability
| Metric | HIND | LEXX | Biotechnology median |
|---|---|---|---|
| Gross margin | 50.39% | 99.62% | 70.18% |
| Operating margin | (2,851.63%) | (1,683.06%) | 0.00% |
| Net margin | (2,453.92%) | (1,686.05%) | 0.00% |
| Free cash flow margin | (2,928.92%) | (1,494.56%) | 0.00% |
| Return on equity | (71.85%) | (162.60%) | (51.58%) |
| Return on assets | (48.02%) | (134.20%) | (45.91%) |
| Return on invested capital | 0.00% | (662.56%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack